148 related articles for article (PubMed ID: 37157963)
1. Association between occurrence of multiple white and flat elevated gastric lesions and oral proton pump inhibitor intake.
Hasegawa R; Yao K; Kanemitsu T; Arima H; Hirase T; Hiratsuka Y; Takeda K; Imamura K; Ohtsu K; Ono Y; Miyaoka M; Hisabe T; Ueki T; Tanabe H; Ohta A; Nimura S
Clin Endosc; 2024 Jan; 57(1):65-72. PubMed ID: 37157963
[TBL] [Abstract][Full Text] [Related]
2. Magnified Endoscopic Findings of Multiple White Flat Lesions: A New Subtype of Gastric Hyperplastic Polyps in the Stomach.
Hasegawa R; Yao K; Ihara S; Miyaoka M; Kanemitsu T; Chuman K; Ikezono G; Hirano A; Ueki T; Tanabe H; Ota A; Haraoka S; Iwashita A
Clin Endosc; 2018 Nov; 51(6):558-562. PubMed ID: 30458604
[TBL] [Abstract][Full Text] [Related]
3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients.
Snir Y; Leibovitzh H; Leibovici-Weissman Y; Vilkin A; Cohen AD; Shochat T; Niv Y; Dotan I; Feldhamer I; Boltin D; Levi Z
United European Gastroenterol J; 2021 Apr; 9(3):343-353. PubMed ID: 32962566
[TBL] [Abstract][Full Text] [Related]
5. Effects of Proton Pump Inhibitor Therapy,
Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study.
Kiso M; Ito M; Boda T; Kotachi T; Masuda K; Hata K; Sasaki A; Kawamura T; Yoshihara M; Tanaka S; Chayama K
Scand J Gastroenterol; 2017 Aug; 52(8):828-832. PubMed ID: 28485638
[TBL] [Abstract][Full Text] [Related]
7. Influence of proton pump inhibitor use in gastrointestinal polyps.
Hsu WH; Wu IC; Kuo CH; Su YC; Lu CY; Kuo FC; Jan CM; Wang WM; Wu DC; Yu FJ
Kaohsiung J Med Sci; 2010 Feb; 26(2):76-83. PubMed ID: 20123595
[TBL] [Abstract][Full Text] [Related]
8. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
[TBL] [Abstract][Full Text] [Related]
9. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
11. Intake of Proton-Pump Inhibitors and Gastric Cancer within the Stomach Cancer Pooling (StoP) Project.
Sassano M; Mariani M; Pelucchi C; Lunet N; Morais S; Martín V; Moreno V; Curado MP; Dias-Neto E; Leja M; Gašenko E; La Vecchia C; Boccia S; Pastorino R
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1174-1181. PubMed ID: 37364052
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
Waldum HL; Sørdal Ø; Fossmark R
Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.
Takahari K; Haruma K; Ohtani H; Kiyoto S; Watanabe A; Kamada T; Manabe N; Hatano Y
Intern Med; 2017 Oct; 56(20):2699-2703. PubMed ID: 28924108
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Kanno T; Yuan Y; Tse F; Howden CW; Moayyedi P; Leontiadis GI
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD005415. PubMed ID: 34995368
[TBL] [Abstract][Full Text] [Related]
15. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
16. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitor-Related Gastric Mucosal Changes.
Kim GH
Gut Liver; 2021 Sep; 15(5):646-652. PubMed ID: 32327613
[TBL] [Abstract][Full Text] [Related]
18. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
20. The effect of proton pump inhibitors on the gastric mucosal microenvironment.
Peng YC; Huang LR; Ho HC; Chang CS; Lee SW; Cheng CC; Wen MC; Yeh HZ; Ho SP
Adv Clin Exp Med; 2017; 26(1):39-43. PubMed ID: 28397430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]